Flavonoids in the Treatment of Alzheimer’s and Other Neurodegenerative Diseases

E-ISSN： 1875-533x|25|27|3228-3246

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.25, Iss.27, 2018-08, pp. : 3228-3246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer’s disease and other neurodegenerative disorders

By Castro A. Martinez A.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 10, 2000-10 ,pp. : 1519-1527

Informa Healthcare

Access to resources Recommend Favorite

Tocopherol (Vitamin E) in Alzheimers Disease and Other Neurodegenerative Disorders

By Karen Berman Henry Brodaty

CNS Drugs, Vol. 18, Iss. 12, 2004-01 ,pp. : 807-825

Adis International

Access to resources Recommend Favorite

Tau protein as a therapeutic target in Alzheimer’s disease and other neurodegenerative disorders

By Larner A.J.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 10, 1999-10 ,pp. : 1359-1370

Informa Healthcare

Access to resources Recommend Favorite

Pharmaceutical treatment for cognitive deficits in Alzheimer’s disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps

By Bartus Raymond Dean Reginald

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 15-36

Springer Publishing Company

Access to resources Recommend Favorite

Current Progresses on Nanodelivery Systems for the Treatment of Neuropsychiatric Diseases: Alzheimer’s and Schizophrenia

Current Pharmaceutical Design, Vol. 19, Iss. 41, 2013-12 ,pp. : 7185-7195

Bentham Science Publishers

Access to resources Recommend Favorite